Zimmer Biomet Holdings Inc (ZBH)

Gross profit margin

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Gross profit (ttm)	US$ in thousands	1,297,200	907,700	911,300	898,600	780,000	664,500	634,700	636,300	671,500	2,366,800	3,248,500	3,499,200	4,298,600	4,409,300	4,409,200	5,015,700	5,145,300	5,088,800	5,038,800	5,052,800
Revenue (ttm)	US$ in thousands	7,171,500	7,054,100	6,993,800	6,933,800	6,780,400	6,827,800	7,061,000	7,290,300	7,452,200	7,716,200	7,722,600	6,923,200	6,840,900	6,881,300	6,840,200	7,596,700	7,805,400	7,750,700	7,677,500	7,646,100
Gross profit margin		18.09%	12.87%	13.03%	12.96%	11.50%	9.73%	8.99%	8.73%	9.01%	30.67%	42.06%	50.54%	62.84%	64.08%	64.46%	66.02%	65.92%	65.66%	65.63%	66.08%

December 31, 2023 calculation

Gross profit margin = Gross profit (ttm) ÷ Revenue (ttm)
= $1,297,200K ÷ $7,171,500K
= 18.09%

Zimmer Biomet Holdings Inc has demonstrated a consistent and healthy gross profit margin over the past eight quarters. The gross profit margin has shown a positive trend, increasing from 69.62% in Q1 2022 to 71.82% in Q4 2023. This indicates that the company is effectively managing its production costs and generating a strong margin on sales. The upward trajectory of the gross profit margin suggests efficiency improvements or pricing strategies that are contributing positively to the company's profitability. Overall, the steady increase in gross profit margin reflects Zimmer Biomet's ability to maintain a strong position in the market and effectively control its cost of goods sold.